NCT03459963

Brief Summary

This study aims to compare the routine use versus non-use of urethral catheterization in women undergoing first elective cesarean section as regard to intraoperative and postoperative complications

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 18, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 28, 2018

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 9, 2018

Completed
23 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2018

Completed
Last Updated

March 9, 2018

Status Verified

March 1, 2018

Enrollment Period

7 months

First QC Date

February 28, 2018

Last Update Submit

March 8, 2018

Conditions

Keywords

cathetercesarean sectionurinary tract infectionpatient's satisfaction

Outcome Measures

Primary Outcomes (1)

  • Presence of UTI

    midstream urine samples were collected 24 hours postoperatively after giving the instructions to the patients and tested for presence of UTI. These fresh non-centrifuged urine samples were collected and tested for leukocyte esterase and nitrite using (Convergys urine matrix 10, Germany) strips. Nitrite will be considered positive if there is change in color of dipstick from colorless towards pink within 60 seconds. Leukocyte esterase will be considered positive if there is change in color from off-white towards purple within 2 minutes

    24-h postoperative

Secondary Outcomes (7)

  • Operative duration

    intraoperative

  • Bladder injury incidence.

    intraoperative

  • Intraoperative need of urethral catheter in N group

    intraoperative

  • Ambulation time

    intraoperative

  • Postpartum hemorrhage

    first postoperative day

  • +2 more secondary outcomes

Study Arms (2)

group C

EXPERIMENTAL

indwelling urinary catheter

Device: indwelling urinary catheter

group N

NO INTERVENTION

Non cathetrized patients

Interventions

85 women undergoing first elective CS will be catheterized immediately preoperatively using Foley's catheter by applying catheterization precautions.

group C

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Pregnant women undergoing first elective CS at term pregnancy (37-41w gestation).
  • haemodynamically stable

You may not qualify if:

  • History of recurrent UTI during pregnancy, current UTI
  • presence of Medical complications that requiring special care e.g: diabetes with pregnancy, hypertensive disorders with pregnancy, cardiac disease, chronic renal disease,
  • previous cesarean section
  • Previous abdominal surgery which may be associated with extensive adhesions, -polyhydraminos
  • fetal macrosomia
  • significant vaginal bleeding
  • Contraindication for the antibiotic used e.g: anaphylaxis
  • Need for extensive use of antibiotics more than the prophylactic dose
  • Spinal anesthesia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ain Shams University Maternity Hospital.

Cairo, Egypt

Location

MeSH Terms

Conditions

Urinary Tract Infections

Condition Hierarchy (Ancestors)

InfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Officials

  • Tamer F borg

    Ain Shams Maternity Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor

Study Record Dates

First Submitted

February 28, 2018

First Posted

March 9, 2018

Study Start

May 18, 2017

Primary Completion

December 20, 2017

Study Completion

April 1, 2018

Last Updated

March 9, 2018

Record last verified: 2018-03

Locations